ESSA PHARMA

essa-pharma-logo

ESSA is a pharmaceutical company focused on the development of small molecule drugs for the treatment of cancer, with a focus on advanced prostate cancer. ESSA is developing drugs that selectively block the N-terminal domain of the androgen receptor (AR). The AR is required for the growth and survival of most prostate cancer; therefore, the AR N-terminal domain is an ideal target for next-generation hormone therapy.

#SimilarOrganizations #People #Financial #Website #More

ESSA PHARMA

Social Links:

Industry:
Biopharma Biotechnology Pharmaceutical

Founded:
2009-01-01

Address:
Vancouver, British Columbia, Canada

Country:
Canada

Website Url:
http://www.essapharma.com

Total Employee:
11+

Status:
Active

Contact:
(832) 831-5958

Email Addresses:
[email protected]

Total Funding:
280.73 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

axcella-logo

Axcella

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

day-one-biopharmaceuticals-logo

Day One Biopharmaceuticals

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

vor-biopharma-logo

Vor Biopharma

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.


Current Advisors List

david-parkinson_image

David Parkinson Member of the Board of Directors @ ESSA Pharma
Board_member
2015-05-24

gary-sollis_image

Gary Sollis Member of the Board of Directors @ ESSA Pharma
Board_member
2012-04-01

not_available_image

Hugo Beekman Board Member @ ESSA Pharma
Board_member

scott-requadt_image

Scott Requadt Member of the Board of Directors @ ESSA Pharma
Board_member

richard-glickman_image

Richard Glickman Chairman of the Board of Directors @ ESSA Pharma
Board_member
2010-10-01

marianne-sadar_image

Marianne Sadar Member of the Board of Directors @ ESSA Pharma
Board_member
2009-01-01

franklin-berger_image

Franklin Berger Member of the Board of Directors @ ESSA Pharma
Board_member

raymond-andersen_image

Raymond Andersen Member of the Board of Directors @ ESSA Pharma
Board_member
2009-01-01

Current Employees Featured

david-parkinson_image

David Parkinson
David Parkinson President & CEO @ ESSA Pharma
President & CEO
2016-01-07

paul-cossum_image

Paul Cossum
Paul Cossum Executive Vice President of Research & Development @ ESSA Pharma
Executive Vice President of Research & Development
2014-04-01

david-wood_image

David Wood
David Wood CFO @ ESSA Pharma
CFO
2013-10-01

marianne-sadar_image

Marianne Sadar
Marianne Sadar Scientific Founder @ ESSA Pharma
Scientific Founder
2009-01-01

alessandra-cesano_image

Alessandra Cesano
Alessandra Cesano Chief Medical Officer @ ESSA Pharma
Chief Medical Officer
2019-07-01

raymond-andersen_image

Raymond Andersen
Raymond Andersen Co-Founder & CTO @ ESSA Pharma
Co-Founder & CTO
2009-01-01

Founder


marianne-sadar_image

Marianne Sadar

raymond-andersen_image

Raymond Andersen

Stock Details


Company's stock symbol is NASDAQ:EPIX

Acquisitions List

Date Company Article Price
2019-05-16 Realm Therapeutics Realm Therapeutics acquired by ESSA Pharma N/A

Investors List

bvf-partners_image

BVF Partners

BVF Partners investment in Post-IPO Equity - ESSA Pharma

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Post-IPO Equity - ESSA Pharma

pfizer-breakthrough-growth-initiative_image

Pfizer Breakthrough Growth Initiative

Pfizer Breakthrough Growth Initiative investment in Post-IPO Equity - ESSA Pharma

vivo-capital_image

Vivo Capital

Vivo Capital investment in Post-IPO Equity - ESSA Pharma

camcapital_image

CAM Capital

CAM Capital investment in Post-IPO Equity - ESSA Pharma

avidity-partners_image

Avidity Partners

Avidity Partners investment in Post-IPO Equity - ESSA Pharma

ridgeback-capital_image

Ridgeback Capital

Ridgeback Capital investment in Post-IPO Equity - ESSA Pharma

sphera-global-health-care-fund_image

Sphera Global Healthcare Fund

Sphera Global Healthcare Fund investment in Post-IPO Equity - ESSA Pharma

pfizer_image

Pfizer

Pfizer investment in Post-IPO Equity - ESSA Pharma

point72_image

Point72

Point72 investment in Post-IPO Equity - ESSA Pharma

Official Site Inspections

http://www.essapharma.com Semrush global rank: 8.76 M Semrush visits lastest month: 261

  • Host name: 37.115.215.35.bc.googleusercontent.com
  • IP address: 35.215.115.37
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "ESSA Pharma"

ESSA Pharma - LinkedIn

ESSA is a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer. ESSAโ€™s lead clinical candidate, EPI-7386, represents a new โ€ฆ See details»

ESSA Pharma - Crunchbase Company Profile & Funding

ESSA Pharma is a biotechnology company that develops new drugs for prostate cancer. See details»

ESSA Pharma (EPIX) Company Profile & Description

Jul 9, 2025 Company profile for ESSA Pharma Inc. (EPIX) stock, with a description, list of executives, contact details and other key facts. See details»

ESSA Pharma Inc Company Profile | Management and Employees โ€ฆ

Find contact information for ESSA Pharma Inc. Learn about their Research & Development, Business Services market share, competitors, and ESSA Pharma Inc's email format. See details»

Essa Pharma - Developing the Next Generation of โ€ฆ

ESSA is a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer. ESSAโ€™s lead clinical candidate, masofaniten (formerly EPI-7386), represents a new approach to disrupting the โ€ฆ See details»

ESSA Pharma Inc. Announces Definitive Agreement to be

3 days ago T: 778-331-0962 E: [email protected] or Nick Lamplough / Dan Moore [email protected] XenoTherapeutics Contact Information: Jon Adkins โ€ฆ See details»

ESSA is developing proprietary therapies for prostate โ€ฆ

Essa is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of prostate cancer. Prostate cancer is predominantly driven by the androgen receptor (AR). The current standard of โ€ฆ See details»

ESSA Pharma - Craft

ESSA Pharma has 5 employees across 3 locations. See insights on ESSA Pharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. See details»

ESSA Pharma - Overview, News & Similar companies | ZoomInfo.com

Apr 9, 2024 View ESSA Pharma (www.essapharma.com) location in British Columbia, Canada , revenue, industry and description. Find related and similar companies as well as employees โ€ฆ See details»

ESSA Pharma Inc. - PRISM MarketView

About ESSA Pharma Inc. ESSA is a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer. ESSAโ€™s lead clinical candidate, EPI-7386, represents a new approach to โ€ฆ See details»

ESSA is developing proprietary therapies for prostate cancer โ€ฆ

Essa is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of prostate cancer. See details»

ESSA Pharma Overview | SignalHire Company Profile

The number of employees ranges from 25 to 100. The annual revenue of ESSA Pharma varies between 5.0M and 25M. Total funding of the company - $114M. To connect with ESSA โ€ฆ See details»

Executive Team - Essa Pharma

Dr. Glickman has served as the founding Chairman of the Board of the Company since October 2010 and is one of Canadaโ€™s best known and most successful healthcare entrepreneurs. Dr. โ€ฆ See details»

ESSA Pharma Inc. Announces Definitive Agreement to be Acquired โ€ฆ

3 days ago T: 778-331-0962 E: [email protected] or Nick Lamplough / Dan Moore [email protected] XenoTherapeutics Contact Information: Jon Adkins โ€ฆ See details»

Site Map - Essa Pharma

400 Oyster Point Blvd., Suite 520South San Francisco, CA 94080 See details»

ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL โ€ฆ

Mar 6, 2025 Contact Information: David Wood Chief Financial Officer, ESSA Pharma Inc. T: 778-331-0962 E: [email protected] About ESSA Pharma Inc. See details»

Essa Pharma Inc. Company Profile | StatInvestor

Essa Pharma Company Profile. Learn more about who Essa Pharma is. Get financial information, who is the owner of Essa Pharma and key facts about Essa Pharma Inc. See details»

Executive Team - Essa Pharma

Merendino also held positions of increasing authority at Genentech in commercial organization across sales, marketing and strategy, with a focus in oncology. Throughout her career, she โ€ฆ See details»

Contact Us - Essa Pharma

British Columbia 999 West Broadway, Suite 720 Vancouver, BC V5Z 1K5 (778) 331-0962 [email protected] See details»

ESSA Pharma CEO and Key Executive Team - Craft.co

ESSA Pharma's Chairman of the Board is Richard Glickman. Other executives include David R. Parkinson, President, Chief Executive Officer & Director; Peter Virsik, Chief Operating Officer, โ€ฆ See details»

linkstock.net © 2022. All rights reserved